Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017
This table browses all dspace content
Issue DateTitleJournal Title
2024Post-Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia-Pacific RegionJOURNAL OF VIRAL HEPATITIS
2024Differentiation Between Invasive Adenocarcinoma and Focal Interstitial Fibrosis among Persistent Pulmonary Part-solid Nodules: With Emphasis on the CT Morphologic AnalysisJOURNAL OF THORACIC IMAGING
2024Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment PracticesHELICOBACTER
2024Efficacy and safety of tegoprazan- and rabeprazole-based concomitant therapies for Helicobacter pylori infection: Real-world evidenceJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2024PM2.5 constituents associated with mortality and kidney failure in childhood-onset lupus nephritis: A 19-year cohort studySCIENCE OF THE TOTAL ENVIRONMENT
2024A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer FUTURE ONCOLOGY
2024국내 중등증 의료서비스 제공 방법에 대한 전문가 의견 조사: 포커스 그룹 인터뷰와 델파이 조사를 활용하여 HIRA Research(건강보험심사평가원 학술지)
2024Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agentsLIVER INTERNATIONAL
2024Clinical impacts of concomitant left atrial appendage occlusion during mitral valve surgery in patients with mitral regurgitation SCIENTIFIC REPORTS
2024Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2024Transthyretin amyloidosis prevalence and characteristics in Korean patients with heart failure with preserved or mildly reduced ejection fractions SCIENTIFIC REPORTS
2024Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in treatment-naïve and treatment-experienced people with HIV: Findings from the Asia cohort of the BICSTaR study JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
2024Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13) CANCER RESEARCH AND TREATMENT
2024Association between Age-Adjusted Endothelial Activation and Stress Index and Intensive Care Unit Mortality in Patients with Severe COVID-19 TUBERCULOSIS AND RESPIRATORY DISEASES
2024Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with longterm antiviral therapy in chronic hepatitis B patients” CLINICAL AND MOLECULAR HEPATOLOGY
2024Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease CLINICAL AND TRANSLATIONAL MEDICINE
2024Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer ONCOLOGIST
2024Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung CancerNEW ENGLAND JOURNAL OF MEDICINE
2024Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study BMC MEDICINE
2024Reply to correspondence on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients” CLINICAL AND MOLECULAR HEPATOLOGY

Browse

Links